The Andalusian Health Service (SAS) has opened the self-appointment for the COVID-19 booster dose for people born in 1983 and 1984. Appointments can be made through the usual channels: the SAS website via ClicSalud+ (http://lajunta.es/2a5ny), the mobile application and the Salud Responde telephone number (955 54 50 60) as well as at your health centre, preferably by telephone.
As for the walk-in vaccination points, all currently prioritised groups will be able to attend: those born in 1983 or earlier who are pending a booster dose; those who received a dose from Janssen or the AstraZeneca regimen; as well as those aged 12 years or older who have yet to start the vaccination process with the first dose or who are awaiting the second dose.
In the case of adults, and following the latest decision taken by the Public Health Commission, the booster dose is indicated if five months, not six, have passed since the second dose of messenger RNA (Pfizer or Moderna). In addition, 3 months after the second dose of AstraZeneca vaccine and 3 months after vaccination with Janssen. In the booster dose, messenger RNA vaccines will be administered.
In the case of children, Pfizer’s specific preparation, in addition to containing a smaller amount of active ingredient, separates the two doses by an interval of eight weeks instead of three.
Throughout Andalusia, vaccination will continue to be carried out in this age group from 11 to 5 years of age, mainly in health centres and external points, although mobile units are also scheduled to intervene.
Vaccination in pregnant women
A booster dose is also recommended for all pregnant women who have already been vaccinated, regardless of their age, if at least five months have passed since the last dose of the full Pfizer or Moderna vaccination schedule; if at least three months have passed since the last dose of the full AstraZeneca schedule; and if at least three months have passed since the Janssen dose.
The SAS also has open self-appointment schedules for people who received the Janssen one-dose regimen and the AstraZeneca two-dose regimen. For people who received Janssen more than three months ago, regardless of their age, a second dose is administered with mRNA vaccines (Pfizer or Moderna). For people who received two doses from AstraZeneca at least three months ago, regardless of age and whether they have passed COVID-19 infection before or after vaccination, messenger RNA vaccine (Pfizer or Moderna) will be administered.
In addition, those over 18 years of age who travel abroad for study or work purposes can also request an appointment for the administration of the booster dose.
For the time being, people who received a dose of AstraZeneca and then a dose of mRNA (Pfizer or Moderna), or vice versa, are not eligible for this booster dose, as it has been observed that the immunity and efficacy of these heterologous guidelines is more potent and prolonged in these cases.
In children under 65 years pending any dose of vaccine (first, second or booster), it should be taken into account if COVID has been passed recently, as it is preferable to wait four weeks for vaccination after the occurrence or diagnosis of the infection. From 65 years of age onwards, the four-week waiting period is not necessary, simply that the person is well and out of isolation.